Wall Street Journal: Health

Syndicate content WSJ.com: Health
Health
Updated: 2 min 8 sec ago

For Wounded Vet, Love Pierces the Fog of War

3 hours 31 min ago
Katie Brickman is both Ian Welch's girlfriend and his government-paid caregiver. Mr. Welch, a former Marine, is dealing with post-traumatic shock from his service in Iraq.

Komen Reverses on Planned Parenthood

Sat, 02/04/2012 - 00:43
The Susan G. Komen for the Cure breast-cancer charity said it was reversing its decision to cut breast-screening grants to Planned Parenthood.

Nonprofits' Backers Mobilize

Fri, 02/03/2012 - 15:05
The Susan G. Komen for the Cure breast-cancer charity grappled with the fallout from its decision to cut funding for Planned Parenthood affiliates, as both groups saw a surge in donations.

Walgreen Same-Store Sales Decline

Fri, 02/03/2012 - 14:22
Walgreen's same-store sales slid 4.6% in January as the drugstore chain's prescriptions sales were battered by the loss of major customer Express Scripts.

AstraZeneca to Cut 7,300 Jobs

Fri, 02/03/2012 - 01:24
AstraZeneca announced it will eliminate another 7,300 jobs, bringing its total cuts over the past five years to nearly 30,000.

Study: Hospitals Overpay for Devices

Thu, 02/02/2012 - 22:41
Some hospitals pay thousands of dollars more than others for big-ticket medical devices such as defibrillators, and a portion of the higher costs could be passed on to Medicare.

Merck Swings to Profit

Thu, 02/02/2012 - 16:50
Drug maker Merck swung to a profit amid fewer acquisition-related and restructuring charges, and it also reported a modest increase in revenue.

Pfizer Recalls Some Birth-Control Pills

Wed, 02/01/2012 - 22:55
Pfizer recalled about a million packs of birth-control pills that weren't packaged correctly and raised the risk of unplanned pregnancies.

Device Makers, FDA Agree on Fees

Wed, 02/01/2012 - 20:43
Medical-device companies reached a tentative deal to pay the FDA $595 million over five years to increase the number of federal workers who approve devices and get new devices on the market faster.

Roche Upbeat as Profit Rises

Wed, 02/01/2012 - 20:00
Swiss pharmaceutical company Roche issued an upbeat outlook for 2012 after reporting a rise in full-year net profit due to tight cost controls and despite a drop in annual sales.

French Report Blames Implant Maker, Officials

Wed, 02/01/2012 - 19:45
The French company at the heart of a scandal over faulty breast implants repeatedly misled and tricked authorities, who themselves neglected warning signs, a French government report said.

FDA Approves Cystic Fibrosis Drug

Wed, 02/01/2012 - 15:12
The FDA approved a new medicine treat an underlying cause of cystic fibrosis, a pill that targets a genetic mutation affecting a small minority of patients suffering from the breathing disorder.

New Strides Against Prostate Cancer

Wed, 02/01/2012 - 15:04
Drug companies have scored a string of recent successes against advanced prostate cancer, ending a long drought during which there seemed to be few weapons to combat the disease.

Dendreon Names New CEO

Wed, 02/01/2012 - 12:38
Dendreon named John H. Johnson, the CEO of Savient Pharmaceuticals, to succeed Mitchell H. Gold as president and CEO.

Takeda Pharmaceutical Profit Falls 26%

Wed, 02/01/2012 - 05:23
Takeda, Japan's biggest drug maker, cut its earnings outlook on streamlining costs after last year's $13.7 billion acquisition of Swiss drug maker Nycomed, while rival Astellas appears headed toward a new growth phase.

Pfizer, Lilly Profits Fall as Drugs Lose Patents

Tue, 01/31/2012 - 22:26
Pfizer and Lilly were hurt by the "patent cliff," with each reporting declines in fourth-quarter profit due to new generic competition for top-selling drugs.

Biogen's Net Rises 25%

Tue, 01/31/2012 - 16:27
Biogen Idec's earnings rose 25%, fueled by rising sales of multiple-sclerosis drugs.

Pfizer Set to Seek Aprela Nod

Tue, 01/31/2012 - 15:13
Pfizer is preparing to seek U.S. regulatory approval to sell a new menopause drug that could pose an alternative to the company's older hormone-replacement therapies.

FDA Approves Skin Cancer Drug

Tue, 01/31/2012 - 15:09
The FDA approved a drug developed by Roche and Curis to treat advanced cases of basal cell skin cancer.

Searching for Side Effects

Tue, 01/31/2012 - 15:08
Two start-up companies have created databases that let consumers search FDA adverse-event reports of prescription drugs and medical devices.